Skip to content

Public FDA record

Z-2163-2025: ACUVUE OASYS MAX 1-Day MULTIFOCAL

Recall record Z-2163-2025 for Johnson & Johnson Vision Care, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2163-2025
Company in FDA record
Johnson & Johnson Vision Care, Inc.
FDA classification date
Jul 23, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to defects (bubbles/voids) identified during standard finished goods testing

Source facts

Action
On 06/12/2025, the firm sent via FedEx an "URGENT: MEDICAL DEVICE RECALL" letter to customers to inform them that the firm identified high density of microbubbles (microscopic voids within the contact lens) observed in specific limited lots during our quality control checks. Customers are instructed to: 1. Review if any of their inventory contains contact lenses impacted lot numbers. 2. STOP using and remove from their inventory all affected product. Note: They can continue to use all other lots not affected by this voluntary recall. 3. Pass this notice on to anyone in their organization who needs to be aware of the issue and ensure that they maintain awareness as necessary. 4. Please contact their patients that may have received any of the affected product and ask them return for replacement. 5. Global Post Market Safety, at 1-800-843-2020, will arrange for the return and replacement of any affected product. 6. Complete the enclosed Customer Reply Form and return via email to vpiweb@visus.jnj.com or via fax to 904-229-0300, EVEN IF CUSTOMERS HAVE NO INVENTORY REMAINING affected by this recall. JJVC requires this information for reconciliation purposes with regulatory agencies. The completed Customer Reply Form should be emailed or faxed within 3 business days of receipt of this letter. For questions or assistance - contact Johnson & Johnson Vision Care Global Post Market Safety, at 1-800-843-2020
Initiated
2025-06-12
Root cause
Nonconforming Material/Component
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, DE, FL, GA, HI, IA, IL, IN, KN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NV, NY, OH, PA, SC TN, TX, UT, VA, WA, WI, and WY. The countries of Belgium, Bermuda, Canada, Switzerland, Denmark, Germany, Spain, France, United Kingdom, Italy, Netherlands, Poland, Sweden, Singapore, and South Korea.
Recall number
Z-2163-2025
Recall status
Open, Classified
CDRH record ID
214527
FDA classified
2025-07-23
Recall event number
97095

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗